| Literature DB >> 24014239 |
Julie Rayes1, Lubka T Roumenina, Jordan D Dimitrov, Yohann Repessé, Mathieu Ing, Olivier Christophe, T Sakari Jokiranta, Lise Halbwachs-Mecarelli, Annie Borel-Derlon, Srinivas V Kaveri, Véronique Frémeaux-Bacchi, Sébastien Lacroix-Desmazes.
Abstract
Vascular endothelial cells (ECs) link hemostasis, thrombosis, and complement. ECs synthesize both the clotting initiator von Willebrand factor (VWF) and the complement regulator factor H (FH). VWF is stored in EC Weibel-Palade bodies (WPBs), but the intracellular location of FH is not well defined. We found that FH colocalizes with VWF in WPBs of human umbilical vein ECs. Moreover, FH bound to VWF with an apparent nanomolar affinity and the complex was present in normal plasma. The binding of VWF to FH enhanced FH cofactor activity toward factor I-mediated downregulation of complement activation. Besides, this interaction inhibited ADAMTS13-mediated proteolysis of VWF and promoted platelet aggregation. Here, we describe a novel interaction between complement and hemostasis. The simultaneous secretion of VWF and FH by activated ECs may promote adhesion of platelets to endothelial injury sites to assure wound healing, simultaneously dampening the proinflammatory effect of complement to limit bystander tissue damage.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24014239 DOI: 10.1182/blood-2013-04-495853
Source DB: PubMed Journal: Blood ISSN: 0006-4971 Impact factor: 22.113